Sign in

CIK 0000818033

  • Accelerated filer

HERON THERAPEUTICS, INC. /DE/

Sign in to watch
Ticker
HRTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
942875566
Phone
+1 858-251-4400
Business address
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA, 92121
Former names
AP PHARMA INC /DE/, ADVANCED POLYMER SYSTEMS INC /DE/
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-21 Johnson Craig A Director Grant or award +3,000 3,840
2020-12-21 Johnson Craig A Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2020-12-21 DAVIS STEPHEN Director Grant or award +3,000 3,000
2020-12-21 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +18,000 18,000
2020-10-30 POYHONEN JOHN President & CCO Other acquisition +637 $11.65 $7K 18,780
2020-10-13 Peraza Lisa VP, Chief Accounting Officer Grant or award · Employee Stock Option (Right to Buy) +103,000 103,000
2020-10-13 Peraza Lisa VP, Chief Accounting Officer Grant or award · Restricted Stock Units +8,833 8,833
2020-10-13 MANHARD KIMBERLY EVP, Drug Development Grant or award · Employee Stock Option (Right to Buy) +120,000 120,000
2020-10-13 MANHARD KIMBERLY EVP, Drug Development Grant or award · Restricted Stock Units +20,000 20,000
2020-10-13 POYHONEN JOHN President & CCO Grant or award · Employee Stock Option (Right to Buy) +170,000 170,000
2020-10-13 POYHONEN JOHN President & CCO Grant or award · Restricted Stock Units +20,000 20,000
2020-10-13 Quart Barry D Chief Executive Officer Grant or award · Employee Stock Option (Right to Buy) +350,000 350,000
2020-10-13 Quart Barry D Chief Executive Officer Grant or award · Restricted Stock Units +58,333 58,333
2020-10-13 Christian Waage Director Grant or award · Stock Option (Right to Buy) +437 437
2020-10-13 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +765 765
2020-05-01 MANHARD KIMBERLY Executive VP, Drug Development Sale −1,158 $13.97 $16K 0
2020-04-30 Quart Barry D Chief Executive Officer Other acquisition +1,158 $12.12 $14K 89,226
2020-04-30 MANHARD KIMBERLY Executive VP, Drug Development Other acquisition +1,158 $12.12 $14K 1,158
2020-04-15 Christian Waage Director Grant or award · Stock Option (Right to Buy) +713 713
2020-04-15 DAVIS STEPHEN Director Grant or award · Stock Option (Right to Buy) +1,426 1,426

Page 29 of 38 · 746 trades